Palhares, Lais C. G. F.
Grandits, Melanie
Stoker, Katie
Chauhan, Jitesh
Sow, Heng Sheng
Fruhwirth, Gilbert O.
Tsoka, Sophia
Birtley, James
Partington, Leanne
Wilson, Tim
Hardaker, Elizabeth
Karagiannis, Sophia N.
Bax, Heather J.
FitzGerald, Kevin https://orcid.org/0009-0005-7004-0483
Article History
Received: 8 November 2024
Accepted: 4 February 2025
First Online: 12 February 2025
Declarations
:
: Not applicable.
: All authors reviewed the manuscript and approved the submitted version. All authors agree to all manuscript contents for publication.
: S.N.K. is a founder and shareholder of Epsilogen Ltd. J.B., L.P. E. H., T.W., and K.F. are employed by Epsilogen Ltd. L.C.G.F.P., M.G., J.C., H.S.S, and H.J.B have been or are employed through a fund provided by Epsilogen Ltd. K.F., J.B., T.W., S.N.K. and H.J.B. declare patents on antibody technologies. All other authors declare no competing interests.